Skip to main content

COVID-19 research studies at CUH

In response to the COVID-19 pandemic Cambridge University Hospitals has put in place measures to help researchers and research infrastructure deliver COVID-19 studies, while supporting the care of patients with COVID-19 by redeployment of resources where necessary.


CUHChief and Principal Investigators of studies have been reviewing whether part or all of their studies need to be put on hold. Many existing studies are now suspended, and the NIHR Clinical Research Network is pausing any studies that are not nationally prioritised COVID-19 studies.

The NIHR has emphasised the need to prioritise COVID-related work, and are putting in place mechanisms for fast-tracking nationally prioritised studies through HRA and MHRA. A COVID-19 and Clinical Research Oversight Group has been established under the governance of the NIHR Cambridge BRC and will review nationally prioritised studies to consider which can be supported locally with the available resources.

The group will also consider proposals for studies to be sponsored by Cambridge University Hospitals and / or the University of Cambridge, but these are likely to need to have national reach or build on unique local capability to meet the threshold for fast -tracking through HRA / MHRA approval processes.

Professor Ian Wilkinson, Director of the Cambridge Clinical Trials Unit (CCTU), is also establishing a committee to review proposals for clinical trials related to COVID-19.

If you have questions, research proposals or clinical trials that you wish to be considered please contact [email protected] in the first instance.

Published March 26th, 2020

Latest from CCTU

National Patient Led Research Hub celebrates tenth anniversary

A national team based in Cambridge are celebrating ten years of helping people living with rare diseases to develop their own research ideas. The hub has…

Hope for MS patients as Cambridge trial suggests drug combination may repair nerve damage

Early findings from a clinical trial in Cambridge suggest a combination of metformin, a diabetes drug, and clemastine, an antihistamine, can help repair…

Prospective study into controversial brain cyst syndrome is world first

The world’s first study of its kind highlights the potential value of surgery to treat a specific kind of brain cyst that blights the lives of patients.

All news